Preterm Labour

Dewhurst's Textbook of Obstetrics & Gynaecology: Eighth Edition

Volumn , Issue , 2012, Pages 338-355

  Bennett, Phillip ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cervix; Infection; Inflammation; Prematurity; Preterm labour; Progesterone; Steroids; Tocolysis; Twins

Indexed keywords

EID: 84885494008     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119979449.ch28     Document Type: Chapter

References (59)

1. Tucker J, McGuire W. Epidemiology of preterm birth. BMJ 2004; 329: 675-678.
2. Murphy DJ. Epidemiology and environmental factors in preterm labour. Best Pract Res Clin Obstet Gynaecol 2007; 21: 773-789.
3. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child 2005; 90: F134-F140.
4. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284: 1417-1424.
5. Leviton A, Paneth N, Reuss ML et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr Res 1999; 46: 566-575.
6. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000; 343: 378-384.
7. Colvin M, McGuire W, Fowlie PW. Neurodevelopmental outcomes after preterm birth. BMJ 2004; 329: 1390-1393.
8. Takashima S, Itoh M, Oka A. A history of our understanding of cerebral vascular development and pathogenesis of perinatal brain damage over the past 30 years. Semin Pediatr Neurol 2009; 16: 226-236.
9. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8: 110-124.
10. Boot FH, Pel JJ, van der Steen J, Evenhuis HM. Cerebral visual impairment: which perceptive visual dysfunctions can be expected in children with brain damage? A systematic review. Res Dev Disabil 2010; 31: 1149-1159.
11. Smith R. Parturition. N Engl J Med 2007; 356: 271-283.
12. Zakar T, Mesiano S. How does progesterone relax the uterus in pregnancy? N Engl J Med 2011; 364: 972-973.
13. Mesiano S, Welsh TN. Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol 2007; 18: 321-331.
14. Lindström TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction 2005; 130: 569-581.
15. Mendelson CR, Condon JC. New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol Biol 2005; 93: 113-119.
16. Shynlova O, Mitchell JA, Tsampalieros A, Langille BL, Lye SJ. Progesterone and gravidity differentially regulate expression of extracellular matrix components in the pregnant rat myometrium. B iol Reprod 2004; 70: 986-992.
17. Smith R, Nicholson RC. Corticotrophin releasing hormone and the timing of birth. Front Biosci 2007; 12: 912-918.
18. Nathanielsz PW. Comparative studies on the initiation of labor. Eur J Obstet Gynecol Reprod Biol 1998; 78: 127-132.
19. Terzidou V, Blanks AM, Kim SH, Thornton S, Bennett PR. Labor and inflammation increase the expression of oxytocin receptor in human amnion. Biol Reprod 2011; 84: 546-552.
20. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-498.
21. Vrachnis N, Vitoratos N, Iliodromiti Z, Sifakis S, Deligeoroglou E, Creatsas G. Intrauterine inflammation and preterm delivery. Ann NY Acad Sci 2010; 1205: 118-122.
22. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553-584.
23. Buhimschi CS, Schatz F, Krikun G, Buhimschi IA, Lockwood CJ. Novel insights into molecular mechanisms of abruption-induced preterm birth. Expert Rev Mol Med 2010; 12: e35.
24. Lockwood CJ. Stress-associated preterm delivery: the role of corticotropin-releasing hormone. Am J Obstet Gynecol 1999; 180: S264-S266.
25. Hoffman HJ, Bakketeig LS. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 1984; 27: 539-552.
26. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007 ;(1): CD000262.
27. Mella MT, Berghella V. Prediction of preterm birth: cervical sonography. Semin Perinatol 2009; 33: 317-324.
28. Honest H, Bachmann LM, Coomarasamy A, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol 2003; 22: 305-322.
29. Sinno A, Usta IM, Nassar AH. A short cervical length in pregnancy: management options. Am J Perinatol 2009; 26: 761-770.
30. MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516-523.
31. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP. Final results of the Cervical Incompetence Prevention Randomised Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001; 185: 1106-1112.
32. Rust OA, Roberts WE. Does cerclage prevent preterm birth? Obstet Gynecol Clin North Am 2005; 32: 441-456.
33. To MS, Alfirevic Z, Heath VC et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Fetal Medicine Foundation Second Trimester Screening Group. Lancet 2004; 363: 1849-1853.
34. Groom KM, Shennan AH, Bennett PR. Ultrasound-indicated cervical cerclage: outcome depends on preoperative cervical length and presence of visible membranes at time of cerclage. Am J Obstet Gynecol 2002; 187: 445-449.
35. Groom KM, Shennan AH, Jones BA, Seed P, Bennett PR. TOCOX: a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005; 112: 725-730.
36. Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990; 97: 149-154.
37. Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomised placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-424.
38. Meis PJ, Klebanoff M, Thom E et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. N Engl J Med 2003; 348: 2379-2385.
39. Rouse DJ, Caritis SN, Peaceman AM et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. N Engl J Med 2007; 357: 454-461.
40. Norman JE, Mackenzie F, Owen P et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373: 2034-2040.
41. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002; 325: 301.
42. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006 ;(3): CD004454.
43. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004 ;(4): CD004352.
44. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005 ;(2): CD001992.
45. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002 ;(4): CD001060.
46. Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and neurological outcome in preterm infants: a systematic review. Obstet Gynecol 2009; 113: 1327-1333.
47. Costantine MM, Weiner SJ. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 2009; 114: 354-364.
48. Romero R, Sibai BM, Sanchez-Ramos L et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomised, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173-1183.
49. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001; 108: 133-142.
50. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomised, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001; 98: 177-185.
51. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001; 97: 840-847.
52. Papatsonis DN, Van Geijn HP, Ad è r HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomised multicenter trial. Obstet Gynecol 1997; 90: 230-234.
53. Coomarasamy A, Knox EM, Gee H, Song F, Khan KS. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. BJOG 2003; 110: 1045-1049.
54. Asztalos EV, Murphy KE, Hannah ME et al. Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes. Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study Collaborative Group. Pediatrics 2010; 126: e1045-e1055.
55. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001; 357: 989-994.
56. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001; 357: 979-988. Erratum in Lancet 2001;358:156.
57. Kenyon S, Pike K, Jones DR et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008; 372: 1310-1318.
58. Aagaard-Tillery KM, Nuthalapaty FS, Ramsey PS, Ramin KD. Preterm premature rupture of membranes: perspectives surrounding controversies in management. Am J Perinatol 2005; 22: 287-297.
59. Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG 2005; 112 ( Suppl 1 ): 32-37.